RYMDF - Relay Medical Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1400
-0.0070 (-4.76%)
At close: 11:36AM EDT
Stock chart is not supported by your current browser
Previous Close0.1470
Open0.1401
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1400 - 0.1401
52 Week Range0.1341 - 0.2179
Volume15,000
Avg. Volume4,221
Market Cap16.085M
Beta (3Y Monthly)2.39
PE Ratio (TTM)N/A
EPS (TTM)-0.0670
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Newsfile17 days ago

    Relay Medical Acquires License to Medical-Grade Cloud Software from Fio Corporation

    Toronto, Ontario--(Newsfile Corp. - July 2, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on the acquisition of rights to a medical-grade cloud software platform, from Fio Corporation, which develops sophisticated healthcare IT solutions for decentralized and mobile settings across the continuum of care, globally. The software, to be marketed as Relay MedNet, has been acquired to substantially ...

  • Relay Medical Develops Pharmatrac Swift, a Plug and Play Solution for Tracking of High Value Medications
    Newsfile21 days ago

    Relay Medical Develops Pharmatrac Swift, a Plug and Play Solution for Tracking of High Value Medications

    Toronto, Ontario--(Newsfile Corp. - June 27, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on extensions to the Pharmatrac platform to address the challenge of tracking expensive medications that are compromised if not properly stored.Highlights:Extended digital medication label design to accommodate blister packs, to broaden the medication packaging form factors with which Pharmatrac is compatible.Completed Pharmatrac Plug 'n' ...

  • Newsfile23 days ago

    Relay Medical Appoints Moshe Katzenelson as Senior Vice President, Global Business Development

    Toronto, Ontario--(Newsfile Corp. - June 26, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to announce the appointment of Moshe Katzenelson as Senior Vice President, Global Business Development.For over 25 years Mr. Katzenelson has played a pivotal role in the advancement of high-tech innovation in Israel's burgeoning technology industry and bringing that innovation to international markets through business development leadership. ...

  • Newsfile2 months ago

    Relay Medical Announces Closing of Private Placement for Proceeds of Over $1.5M

    Toronto, Ontario--(Newsfile Corp. - May 17, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to announce the closing of a private placement financing (the "Offering") for gross proceeds of $1,532,500 through the issuance of 7,662,500 Units (each, a "Unit") at a price of $0.20 per unit. Each Unit is comprised of: (i) one common share in the capital ...

  • Newsfile2 months ago

    Relay Medical Commences Second Pharmatrac User Study and Reports on Development Activities

    Toronto, Ontario--(Newsfile Corp. - May 16, 2019) - Relay Medical Corp. (CSE: RELA) (OTC: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, reports on Pharmatrac development activities and the commencement of a user study on the Pharmatrac in-home countertop medication appliance.In early February the Company reported on the Pharmatrac digital medication label hardware design following the completion of the first Relay-led user study. Following further business development, and user study ...

  • Newsfile2 months ago

    Relay Medical Reports on Technical Advancement of HemoPalm System

    Toronto, Ontario--(Newsfile Corp. - May 14, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on technical advances of the Company's enhanced HemoPalm point-of-care (POC) testing platform.Development Highlights:Demonstrated feasibility of whole blood analysis: The Company's proprietary optical approach has demonstrated accurate measurement of hemoglobin fractions (compared with industry-leading benchtop CO-oximetry analyzer) without red blood cell hemolysis. Relay's ...

  • AgraFlora Organics and Relay Medical Reports on Initial Technology Asset Transfer for Glow LifeTech Ltd.
    CNW Group3 months ago

    AgraFlora Organics and Relay Medical Reports on Initial Technology Asset Transfer for Glow LifeTech Ltd.

    VANCOUVER and TORONTO , April 8, 2019 /CNW/ - AgraFlora Organics International Inc.  ("AgraFlora" or the "Company") (CSE: AGRA) (PU31.F) (PUFXF), a growth oriented and diversified international cannabis company, and Relay Medical Corp. ("Relay") (CSE: RELA, OTCQB: RYMDF, Frankfurt : EIY2), a developer of MedTech innovation, jointly referred to as the "Partners", are pleased to announce the execution of an asset sale agreement ("Agreement") to transfer a suite of technology assets including the cannabis Smart Consumption System from Relay Medical Corp. to Glow LifeTech Ltd. ("Glow"). The technology assets relate largely to the Smart Consumption System ("SCS") currently being developed by Relay Medical to provide users and healthcare professionals with a medical grade, connected hardware/software product line to assist with effective management, storage, curation and consumption of cannabis related products.

  • AgraFlora Organics and Relay Medical Announce Letter of Intent between Glow LifeTech Ltd. and Ateba Resources Inc. for Go-Public Transaction
    CNW Group3 months ago

    AgraFlora Organics and Relay Medical Announce Letter of Intent between Glow LifeTech Ltd. and Ateba Resources Inc. for Go-Public Transaction

    VANCOUVER and TORONTO , April 4, 2019 /CNW/ - AgraFlora Organics International Inc.  ("AgraFlora" or the "Company") (CSE: AGRA) (PU31.F) (PUFXF), a growth oriented and diversified international cannabis company, and Relay Medical Corp. ("Relay") (CSE: RELA, OTCQB: RYMDF, Frankfurt : EIY2), a developer of MedTech innovation, jointly referred to as the "Partners", are pleased to announce the execution of a binding letter of intent ("LOI") to bring Glow LifeTech Ltd. ("Glow"), the cannabis technology joint venture, public by way of reverse takeover. In December 2018 the Partners jointly announced the formation of Glow to identify and develop technologies within the global cannabis sector. "Our initial due diligence into the cannabis technology sector has indicated there is significant demand for new technologies in all levels of the emerging cannabis marketplace," said Derek Ivany , President and CEO, AgraFlora Organics International.

  • Newsfile4 months ago

    Relay Medical Strengthens Board of Directors with Established Software, Financial and Pharma Executives

    Toronto, Ontario--(Newsfile Corp. - April 1, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2)  ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to announce Messrs. Sid Thomas, Medhanie Tekeste and Greg Van Staveren as new appointments to the Company's Board of Directors. The appointments are effective immediately.These appointments are consistent with the Company's expansion and advancement as an integrated MedTech innovator developing technologies for pre-commercial exit transactions and ...

  • Newsfile5 months ago

    Paul Glavina Joins Relay Medical and HemoPalm Team as Vice President, In Vitro Diagnostics

    Toronto, Ontario--(Newsfile Corp. - February 13, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to announce the appointment of Paul Glavina as Vice President, In Vitro Diagnostics, of Relay Medical Corp.Paul is a veteran leader of more than 30 years in the application of biosensors at the point of patient care ("Point of Care Testing", POCT). As Relay's Vice ...

  • Relay Medical Announces Pharmatrac Digital Label Design and Development Activities
    Newsfile5 months ago

    Relay Medical Announces Pharmatrac Digital Label Design and Development Activities

    Toronto, Ontario--(Newsfile Corp. - February 11, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on development activities and hardware design on the Pharmatrac medication management technology. Following the completion of the first Relay led Pharmatrac user study, the Company is pleased to present the Pharmatrac's digital label hardware design.In November 2018 the Company announced the commencement of the ...

  • Newsfile5 months ago

    Relay Medical Reports Progress on Enhanced HemoPalm System Design and Provides Update on Product Development and Market Advancement Activities

    Toronto, Ontario--(Newsfile Corp. - February 7, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on the advancement of the Company's HemoPalm technology and Relay's enhanced HemoPalm system design as well as market advancement activities as the Company continues to build toward productization of this unique point-of-care (POC) testing platform.Relay is developing the HemoPalm technology to provide the in ...

  • Newsfile5 months ago

    Relay Medical Provides 2018 Overview

    Toronto, Ontario--(Newsfile Corp. - February 4, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to provide an overview of operations and developments for 2018.In 2018 Relay Medical made significant advances to the company's business and capabilities, notably changing the leadership, defining and refining the business model, expanding the techno-commercial team, building relevant infrastructure, completing successful financings, successfully completing the ...

  • Relay Medical Corp. and AgraFlora Organics International Inc. Form Glow Life Technologies Ltd. for the Development of Medical Technologies in the Cannabis Sector
    CNW Group7 months ago

    Relay Medical Corp. and AgraFlora Organics International Inc. Form Glow Life Technologies Ltd. for the Development of Medical Technologies in the Cannabis Sector

    VANCOUVER and TORONTO , Dec. 20, 2018 /CNW/ - Relay Medical Corp. ("Relay") (CSE: RELA, OTCQB: RYMDF, Frankfurt: EIY2), a developer of MedTech innovation, and AgraFlora Organics International Inc. ("AgraFlora Organics") (CSE: AGRA) (PU31.F) (PUFXF), a growth oriented and diversified international cannabis company, and jointly referred to as the "Partners", are pleased to announce the formation of the private company Glow Life Technologies Ltd. ("Glow") to pursue medical related technology opportunities in the global cannabis sector. The newly formed entity combines Relay Medical's techno-commercial leadership with AgraFlora Organic's accumulated knowledge, expertise and access to cannabis industries across the sector. Glow Life Technologies  will benefit from Relay Medical's infrastructure, technical leadership and business knowledge for the research, vetting, product development and validation of innovative technologies and AgraFlora will support the Company in the pursuit of technology opportunities in scientific validation, diagnostics, health & safety, screening, compliance and quality control/assurance within the cannabis industry.

  • Newsfile7 months ago

    Relay Medical Appoints Executives; John Soloninka Appointed Senior Vice-President, Acquisitions and Exits; Yoav Raiter as Director, Product Development

    Toronto, Ontario--(Newsfile Corp. - December 13, 2018) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to announce the appointment of John Soloninka as Senior Vice-President of Acquisitions and Exits and Yoav Raiter as Director of Product Development. The appointments have been made in support of the Company's multi-project integrated accelerator model.John Soloninka is a seasoned MedTech executive with over 25 ...

  • Newsfile8 months ago

    Relay Medical Commences User Studies on Pharmatrac Medication Management Technology

    Toronto, Ontario--(Newsfile Corp. - November 20, 2018) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to announce the commencement of user studies on the Company's wholly-owned Pharmatrac medication management technology. In conjunction, Relay Medical has engaged the research and systems design firm Human Factors North Inc. (HFN) to design and manage the Toronto, Ontario based user studies.The user study is the ...

  • Newsfile8 months ago

    Relay Medical Introduces the Pharmatrac Technology and Reports on Development

    Toronto, Ontario--(Newsfile Corp. - November 15, 2018) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to introduce the Company's Pharmatrac Technology and report on related development activities. The Pharmatrac is a UX-centric (user experience) system designed to improve management and identification of medications. The Pharmatrac technology was acquired as part of Relay's recent acquisition of the Ottawa Ontario based UX ...

  • Newsfile8 months ago

    Relay Medical Provides Corporate Update

    Toronto, Ontario--(Newsfile Corp. - November 13, 2018) - Relay Medical Corp. (CSE: RELA) (OTC: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on two propriety software developments and the expansion of the Company's headquarters and development facilities. The software developments include a cloud-based regulatory management system and a modular software development toolkit for rapid prototyping and proprietary development.Relay's techno-commercial team embarked on the internal software ...